Assess microgravity value for nanobody crystallisation and formulation
Biologics developers sometimes use microgravity for crystallisation and formulation; Nanogrow is preclinical, the stage when such studies inform development. G-Space's tool can screen whether a flight is worthwhile.
Evidence from the records
- “Nanobody (sdAb) platform combined with local delivery formulations: topical, nebulized, injectable, oral or via DNA/RNA.”
- “Software platform (founder and CEO: Ioana Cozmuta) that helps biotech and materials companies identify where microgravity offers a commercial advantage and scale up.”
- If it works
- A first biotech assessment project in Latin America.
- First step
- Offer Nanogrow a free microgravity suitability screen.